4//SEC Filing
Brennan Kevin M. 4
Accession 0001415889-23-005764
CIK 0001840233other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:11 PM ET
Size
5.5 KB
Accession
0001415889-23-005764
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2023-04-01+55,000→ 55,000 totalExercise: $3.17Exp: 2033-03-31→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 1, 2023 and shall vest on March 30, 2024 with respect to 25% of the shares of common stock underlying the stock option, and the remaining 75% of the shares of common stock underlying the stock option shall continue to vest in 36 equal monthly installments thereafter until March 30, 2027.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001971303
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:11 PM ET
- Size
- 5.5 KB